This document provides a review of pharmaceuticals and personal care products (PPCPs) in the environment. It discusses the sources and pathways of PPCPs, their environmental effects including endocrine disruption in fish and development of antibiotic resistance in bacteria, and various technologies for removing PPCPs from wastewater such as adsorption, advanced oxidation processes, membrane filtration, and multiple-treatment hybrid processes. It concludes that conventional wastewater treatment needs improvement and more research is still required to fully understand the risks of long-term low-level exposure of PPCPs to humans and the environment.
Original Description:
Pharmaceuticals & Personal Care Products in the Environment
Original Title
Pharmaceuticals & Personal Care Products in the Environment
This document provides a review of pharmaceuticals and personal care products (PPCPs) in the environment. It discusses the sources and pathways of PPCPs, their environmental effects including endocrine disruption in fish and development of antibiotic resistance in bacteria, and various technologies for removing PPCPs from wastewater such as adsorption, advanced oxidation processes, membrane filtration, and multiple-treatment hybrid processes. It concludes that conventional wastewater treatment needs improvement and more research is still required to fully understand the risks of long-term low-level exposure of PPCPs to humans and the environment.
This document provides a review of pharmaceuticals and personal care products (PPCPs) in the environment. It discusses the sources and pathways of PPCPs, their environmental effects including endocrine disruption in fish and development of antibiotic resistance in bacteria, and various technologies for removing PPCPs from wastewater such as adsorption, advanced oxidation processes, membrane filtration, and multiple-treatment hybrid processes. It concludes that conventional wastewater treatment needs improvement and more research is still required to fully understand the risks of long-term low-level exposure of PPCPs to humans and the environment.
Presentation Outline ➢ Introduction ➢ Environmental risks of PPCPs ➢ Technologies for Removing PPCPs ➢ Conclusion and future perspectives What Are They? • Pharmaceuticals and Personal Care Products (PPCPs) Sources and pathways of PPCPs
(Source Ebele et al., 2017)
Classification of PPCPs Environmental Effects • Endocrine disrupting effect on fish - effect of 17α-ethynylestradiol on fathead minnow • Toxic effect on aquatic organisms
(Source: Harada et al., 2008)
Environmental Effects • Antibiotic resistance in bacteria and viruses • Affect natural microbial communities that play a major role in fundamental ecological processes • The toxic mixture effect of the pharmaceuticals are higher than the individual effect (Watanabe et al., 2016) Environmental Effects • PPCPs taken in by humans are estimated to be 9.8 μg per capita per week (Calderon-Preciado et al., 2011) • Lack of data on the direct effect on human body • Damage body function and slow down growth on rats.
(Bartrons and Peñuelas, 2017)
Technologies for Removing PPCPs • Adsorption processes Activated Carbon Metal organic frameworks Advanced oxidation processes (AOPs) • Includes ✓ Ozone (O3) ✓ O3/UV ✓ UV/H2O2 ✓ Fenton oxidation • Effective in degrading PPCPs - Theoretically broken down into harmless components - Must consider degradation products •High operating costs associated with the consumption of energy and chemicals Membrane filtration • Nano filtration (NF) and reverse osmosis (RO) found effective • Membrane bioreactor (MBR) • Removal mechanism (steric exclusion, adsorption and electrostatic repulsion ) • Fouling of membrane negatively affects the removal Multiple-treatment (hybrid) processes • Have been found very effective • Includes ➢ MBR – AOP (Nguyen et al., 2013) ➢ MBR-reverse osmosis (Dolar et al., 2012) ➢ ozonation–biological activated carbon (Reungoat et al., 2012) ➢Membrane ultrafiltration - Activated carbon - ultrasound irradiation (Secondes et al., 2014) Conclusion and future perspectives
• Conventional wastewater treatment methods should be improved
• More attention should be given to hybrid process
• More research is needed on
➢ Effect of continual long-term exposure to low concentrations PPCPs in humans ➢ Additive and synergistic effects ➢ Occurrence and toxicity of PPCPs metabolites and transformation products ➢ low-cost and sustainable wastewater treatment technologies Thank You!